Not Yet Recruiting
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
NCT07454018
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
Not specified